Sarepta Therapeutics, Inc. (SRPT)
22.17
+0.31
(+1.42%)
USD |
NASDAQ |
Dec 09, 16:00
22.04
-0.13
(-0.59%)
After-Hours: 06:52
Sarepta Therapeutics EPS Diluted (Quarterly): -1.795 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Arrowhead Pharmaceuticals, Inc. | -0.175 |
| Amgen, Inc. | 5.934 |
| Bristol Myers Squibb Co. | 1.079 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -179.95M |
| Revenue (Quarterly) | 399.36M |
| Total Expenses (Quarterly) | 579.30M |
| Enterprise Value | 2.722B |
| Gross Profit Margin (Quarterly) | 57.63% |
| Profit Margin (Quarterly) | -45.06% |
| Earnings Yield | -13.05% |
| Normalized Earnings Yield | -7.078 |